SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is surging as investors speculate on a potential buyout following executive severance changes and the highly anticipated upcoming Phase 3 trial data readout. The community is heavily focused on a potential short squeeze, noting record short interest and soaring borrow costs that are fueling significant upward momentum.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio is trending as retail investors speculate on potential inclusion in the Russell 1000 index, driving significant options activity and ongoing conflict between bullish sentiment and short sellers. Community members are actively debating the likelihood of index inclusion while tracking potential catalysts regarding commercialization and regulatory updates.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing intense volatility driven by speculative frenzy and heavy institutional interest surrounding the memory and storage supercycle tied to AI infrastructure demand. The community is sharply divided, with bulls betting on sustained sector growth and potential price target upgrades, while bears warn of a classic bubble cycle and imminent overextension.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is currently trending as investors debate whether the stock is a deep-value opportunity at multi-year lows or a structural value trap heading into earnings. The community remains sharply divided, with bulls pointing to the company's iconic brand status and potential tariff refunds, while bears express skepticism over slowing China sales, heavy competition, and recent management changes.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending due to the volatility surrounding its all-stock acquisition of Synaptics, as market participants weigh the potential for long-term expansion into edge and physical AI against immediate concerns regarding equity dilution. While the stock has faced sharp downward pressure following the deal announcement, community discussion is divided between those bracing for further technical retesting and bulls viewing the current price levels as an attractive entry point for a long-term strategic play.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing intense community focus as investors prepare for an upcoming AGM where the redomiciling plan to the U.S. is expected to be a primary catalyst for institutional interest. Market participants are actively debating the company's manufacturing ramp-up and recent strategic partnership developments while balancing volatility driven by broader sector trends and pending class-action deadlines.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending as investors closely monitor a pivotal court hearing regarding commercial distribution rights ahead of the expected late-August FDA decision for its Duchenne muscular dystrophy therapy, Deramiocel. The community is actively debating the legal battle with Nippon Shinyaku while expressing strong optimism about the therapy's clinical data and potential for broad label approval.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. It operates through the Steelmaking and Other Businesses segments. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is currently facing significant selling pressure and volatility, with the community actively debating whether the stock is undergoing market manipulation or reflecting genuine concerns regarding high debt levels and operational management. Investors are closely monitoring potential developments regarding a partnership with POSCO and the broader impact of hot-rolled coil steel prices on future earnings.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as retail investors rally to trigger a potential short squeeze, fueled by community efforts to lock up the float and push the price above key technical levels. Investors are actively discussing the stock's undervaluation, high dividend yield, and potential for institutional buyouts as catalysts to drive a sustained upward move.

AbCellera Biologics, Inc. engages in the development of therapeutic antibodies. It offers antibody discovery platform that searches, decodes and analyzes natural immune systems to find antibodies that can be developed to prevent and treat disease. The company was founded by Carl Lars G. Hensen, Kathleen Lisaingo, Kevin Heyries, Véronique Lecault and Daniel Da Costa on November 8, 2012 and is headquartered in Vancouver, Canada.

AbCellera Biologics Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Western Midstream (WES) Declines More Than Market: Some Information for Investors

In the most recent trading session, Western Midstream (WES) closed at $42.11, indicating a -3.22% shift from the previous trading day.

Western Midstream Announces Pricing of Notes Offering

Western Midstream Announces Pricing of Notes Offering Western Midstream Announces Pricing of Notes Offering PR Newswire HOUSTON, June 22, 2026 HOUSTON, June 22, 2026 /PRNewswire/ -- Western Midstream Partners, LP (NYSE: WES) ("WES" or the "Partnership") announced today that its subsidiary, Western...

Western Midstream (WES) Stock Sinks As Market Gains: Here's Why

Western Midstream (WES) closed the most recent trading day at $42.96, moving 1.65% from the previous trading session.

Western Midstream Announces Start-up of Second Produced-Water Treatment Facility in the Permian Basin

Western Midstream Announces Start-up of Second Produced-Water Treatment Facility in the Permian Basin Western Midstream Announces Start-up of Second Produced-Water Treatment Facility in the Permian Basin PR Newswire HOUSTON, June 17, 2026 The produced-water treatment pilot facility is a Joint...

Is Targa Resources Stock a Smart Hold in Today's Market?

TRGP surges almost 59% in a year, backed by major growth projects, LPG export expansion and earnings growth outlook despite key risks.

Western Midstream (WES) Exceeds Market Returns: Some Facts to Consider

Western Midstream (WES) reached $44.57 at the closing of the latest trading day, reflecting a +1.43% change compared to its last close.

Western Midstream Announces Closing of Brazos Delaware Acquisition

Western Midstream Announces Closing of Brazos Delaware Acquisition Western Midstream Announces Closing of Brazos Delaware Acquisition PR Newswire HOUSTON, June 11, 2026 HOUSTON, June 11, 2026 /PRNewswire/ -- Western Midstream Partners, LP ("WES" or the "Partnership") (NYSE: WES) today announced it...

Why Is Western Midstream (WES) Up 4.1% Since Last Earnings Report?

Western Midstream (WES) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Western Midstream Q1 Earnings Beat on Higher Throughput Volume

WES Q1 earnings top estimates as higher natural gas, crude oil and water throughput boosts revenues and cash flow growth.

Western Midstream Announces First-Quarter Post-Earnings Interview with CEO, Oscar Brown and VP, Jon Greenberg

Western Midstream Announces First-Quarter Post-Earnings Interview with CEO, Oscar Brown and VP, Jon Greenberg Western Midstream Announces First-Quarter Post-Earnings Interview with CEO, Oscar Brown...

Western Midstream Partners LP engages in the ownership, operation, acquisition, and development of midstream energy assets. It engages in the business of gathering, processing, compressing, treating, and transporting natural gas, condensate, natural gas liquids, and crude oil for Anadarko, as well as third-party producers and customers. The company was founded in 2007 and is headquartered in The Woodlands, TX.

Western Midstream Partners LP - Unit

Bullish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$42.90
Prev Close	$42.78
Open	$42.96
Dividend Yield	9.13%
50-Day Moving Average	$43.42
Beta	0.56
Avg. Volume	1.62M
PE Ratio	13.98

52-Week High	$48.01
52-Week Low	$36.90
Market Capitalization	$16.85B
EPS (Annual)	$2.98
Price to Book	5.00
Revenue Per Employee	$2.26M

Feed

News

Sentiment

Earnings

Fundamentals

Info

WESWestern Midstream Partners LP - Unit

Latest WES News